DexCom, Inc.
Capitalización de mercado
$29.4B
Puesto mundial
#303
Máximo histórico
$51.8B
2021-12-31
Crecimiento total
+0%
desde 2026
Market Cap Context
- Larger than 17% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #302 adidas AG ($29.8B)
- Just below: #304 The Kraft Heinz Company ($29.4B)
- Best year: 2009 (+192%). Worst year: 2008 (-69%).
DexCom, Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance — DXCM annual filings (2025) →$4.7B revenue · $0.9B operating income · $0.8B net income
- ●Operating margin: 19.6% on $4.7B in revenue.
- ●R&D is 12.9% of revenue ($0.6B).
- ●Net income margin: 17.9% — $0.8B in profit.
- ●Free cash flow: $1.1B (23.1% of revenue).
Cost / Operating Expenses
Total operating expenses $3.8B
Total
$3.8B
Capital Expenditures
$0.4B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$1.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Acerca de DexCom, Inc.
DexCom, Inc. (DXCM) is a United States-based company in the Medical Devices industry, part of the Healthcare sector. With a current market capitalization of $29.4B, it is ranked #303 among the world's largest companies. Its market cap peaked at $51.8B and reached as high as rank #199 in 2021.
Historial de capitalización de mercado de DexCom, Inc. (2026–2026)
DexCom, Inc. vs Sector Peers by Market Cap
Comparar DexCom, Inc.
Historial de clasificación
| Año | Capitalización de mercado | Puesto | Variación interanual |
|---|---|---|---|
| 2026 | $29.4B | #303(↑16) | +14.8% |
| 2025 | $25.6B | #319(↓21) | -14.7% |
| 2024 | $30.0B | #298(↓70) | -37.3% |
| 2023 | $47.9B | #228(↓26) | +9.6% |
| 2022 | $43.7B | #202(↓3) | -15.6% |
| 2021 | $51.8B | #199(↑31) | +45.2% |
| 2020 | $35.7B | #230(↑40) | +69.0% |
| 2019 | $21.1B | #270(↑21) | +82.6% |
| 2018 | $11.6B | #291(↑15) | +108.7% |
| 2017 | $5.5B | #306(↓11) | -3.9% |
| 2016 | $5.8B | #295(↓24) | -27.1% |
| 2015 | $7.9B | #271(↑11) | +48.8% |
| 2014 | $5.3B | #282(↑7) | +55.5% |
| 2013 | $3.4B | #289(↑2) | +160.6% |
| 2012 | $1.3B | #291(↓2) | +46.0% |
| 2011 | $898.1M | #289(↓6) | -31.8% |
| 2010 | $1.3B | #283(↓3) | +69.1% |
| 2009 | $778.5M | #280(↑2) | +192.4% |
| 2008 | $266.3M | #282(↓8) | -68.7% |
| 2007 | $851.8M | #274(↓8) | -10.4% |
| 2006 | $951.2M | #266(↓8) | -33.9% |
| 2005 | $1.4B | #258 |
Otras empresas del sector Salud
Preguntas frecuentes
What is DexCom, Inc.'s market cap?
DexCom, Inc. (DXCM) has a market capitalization of $29.4B, making it the #303 largest company in the world by market cap.
What was DexCom, Inc.'s highest market cap?
DexCom, Inc.'s all-time high market cap was $51.8B, reached in 2021-12-31. Its highest rank was #199 in 2021.
What sector is DexCom, Inc. in?
DexCom, Inc. is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has DexCom, Inc.'s market cap changed over time?
DexCom, Inc. has been tracked since 2026. Its market cap has grown by 0% from $29.4B in 2026 to $29.4B today.